27 results on '"Deborah Martinez"'
Search Results
2. Using Comic-Based Concussion Discharge Instructions to Address Caregiver Health Literacy in the Emergency Department
- Author
-
Tom N. Pham, Andrea K. Morrison, Michael S. Menard, Deborah Martinez, and Danny G. Thomas
- Subjects
Emergency Nursing - Abstract
This study compared the effectiveness of comic-based with text-based concussion discharge instructions on improving caregiver knowledge. This study also examined the role of social determinants of health on comprehension instructions.This was an observational study of the caregivers of pediatric concussion patients. Caregivers' health literacy and demographics related socioeconomic factors were obtained. After the patients' evaluation in the emergency department, caregivers were given printed comic-based concussion discharge instructions. Caregivers were contacted 3 days later and tested overall knowledge of discharge instructions' content. These survey results were compared with historical controls who received text-based instructions.A total of 120 participants were recruited, and 86 participants completed follow-up procedures. When comparing the caregivers' recall ability with a comic-based vs traditional text-based instructions, caregivers with comic-based content were more likely to accurately recall overall discharge instructions (77.5% vs 44%, P.001), particularly physical rest and activity restrictions (86.5% vs 63%, P.001). Caregivers also were less likely to misidentify a red flag symptom (7.5% vs 19%, P.04). Comic-based instructions did not increase recall of cognitive rest instructions or postconcussive symptoms. When examining demographic factors, caregivers who could not recall 3 postconcussive symptoms were more likely to be Hispanic or Black, less likely to be college educated, and more likely to have low health literacy.Novel methods should be explored to adequately prepare caregivers for continuing postconcussive care at home. Discharge instructions must be tailored to address caregivers' baseline health literacy and how caregivers digest and retain information.
- Published
- 2023
- Full Text
- View/download PDF
3. P-438 Castleman disease: histopathologic reclassification, clinical characteristics and endpoints in a reference center in Mexico
- Author
-
Baños, Deborah Martinez, primary, Collazo, Alfonso Orozco, additional, Montes, Daniel Montante, additional, Rodriguez, Sergio Rodriguez, additional, Carrera, Isabel Garcia, additional, Lopez, Jesus Sandoval, additional, Thiebaud, Maria Jose Lizardo, additional, Ramos, Cinthya Monroy, additional, Gilardi, Berta Riveros, additional, and Sorsby, Alec Seidman, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Automatic Selection of White Paint Types for Automotive Industry
- Author
-
Deborah Martinez-Camacho, Daniel A. May-Arrioja, Miguel Torres-Cisneros, and Rafael Guzman-Cabrera
- Published
- 2022
- Full Text
- View/download PDF
5. The aspirational income hypothesis: On the limits of the relative income hypothesis
- Author
-
Deborah Martinez Villarreal, Siyu Wang, Jason A. Aimone, Daniel Houser, Kun Qian, and Elias L. Khalil
- Subjects
Organizational Behavior and Human Resource Management ,Economics and Econometrics ,Public economics ,Relative income ,media_common.quotation_subject ,05 social sciences ,Rank (computer programming) ,Peer group ,06 humanities and the arts ,0603 philosophy, ethics and religion ,Ranking ,060302 philosophy ,0502 economics and business ,Happiness ,Economics ,050207 economics ,health care economics and organizations ,media_common - Abstract
According to the “relative income hypothesis,” decision makers derive positive utility from identifying with a group that performs more poorly than they do. We hypothesize that decision makers simultaneously derive negative utility from identifying with such a group. The reason is that decision makers aspire toward status, and thus prefer to identify with a group that is more successful than they are. We call such proposed reason the “aspirational income hypothesis.” If the aspirational income effect dominates the relative income effect, decision makers would prefer to join groups with higher rank than their own. We report data from an experiment that supports the aspirational income hypothesis. It shows that the hypothesis holds (at a weaker intensity) even when it is costly to join a higher ranking group.
- Published
- 2021
- Full Text
- View/download PDF
6. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
- Author
-
Kastritis E., Palladini G., Minnema M. C., Wechalekar A. D., Jaccard A., Lee H. C., Sanchorawala V., Gibbs S., Mollee P., Venner C. P., Lu J., Schonland S., Gatt M. E., Suzuki K., Kim K., Cibeira M. T., Beksac M., Libby E., Valent J., Hungria V., Wong S. W., Rosenzweig M., Bumma N., Huart A., Dimopoulos M. A., Bhutani D., Waxman A. J., Goodman S. A., Zonder J. A., Lam S., Song K., Hansen T., Manier S., Roeloffzen W., Jamroziak K., Kwok F., Shimazaki C., Kim J. -S., Crusoe E., Ahmadi T., Tran N., Qin X., Vasey S. Y., Tromp B., Schecter J. M., Weiss B. M., Zhuang S. H., Vermeulen J., Merlini G., Comenzo R. L., Bradley Augustson, Fiona Kwok, Peter Mollee, Simon Gibbs, Chantal Doyen, Greet Bries, Isabelle Vande Broek, Ka Lung Wu, Koen Theunissen, Koen Van Eygen, Michel Delforge, Nathalie Meuleman, Philip Vlummens, Angelo Maiolino, Breno Moreno de Gusmão, Carlos Eduardo Miguel, Edvan Crusoe, Fernanda Moura, Fernanda Seguro, Jandey Bigonha, Juliane Musacchio, Karla Zanella, Laura Garcia, Marcelo Eduardo Zanella Capra, Reijane Alves de Assis, Rosane Bittencourt, Vania Hungria, Walter Braga, Wolney Barreto, Christopher Venner, Donna Reece, Emilie Lemieux-Blanchard, Kevin Song, Michael Sebag, Selay Lam, Victor Zepeda, Haitao Zhang, Jianda Hu, Jin Lu, Juan Li, Songfu Jiang, Ting Niu, Wenming Chen, Xiaonong Chen, Zhen Cai, Zhou Fude, Maja Oelholm Vase, Morten Salomo, Niels Abildgaard, Alain Fuzibet, Anne-Marie Stoppa, Arnaud Jaccard, Bertrand Arnulf, Bruno Moulin, Bruno Royer, David Ghez, Denis Caillot, Dominique Chauveau, Franck Bridoux, Lauriane Clement-Filliatre, Lionel Karlin, Lotfi Benboubker, Mamoun Dib, Margaret Macro, Mohamad Mohty, Olivier Decaux, Olivier Hermine, Olivier Tournilhac, Philippe Moreau, Salomon Manier, Sylvain Choquet, Véronique Dorvaux, Alexander Carpinteiro, Axel Nogai, Britta Besemer, Christoph Roellig, Roland Fenk, Stefan Knop, Stefan Schönland, Timon Hansen, Argiris Symeonidis, Efstathios Kastritis, Gabor Mikala, Tamás Masszi, Zsolt Nagy, Celia Suriu, Hila Magen, Iuliana Vaxman, Lev Shvidel, Meir Preis, Moshe Gatt, Noa Lavi, Osnat Jarchowsky, Tamar Tadmor, Yael Cohen, Angelo Vacca, Giovanni Palladini, Mario Boccadoro, Maurizio Martelli, Maurizio Musso, Michele Cavo, Chihiro Shimazaki, Hiroyuki Takamatsu, Kazutaka Sunami, Kenshi Suzuki, Nagaaki Katoh, Shinsuke Iida, Takayuki Ikezoe, Tomoaki Fujisaki, Yuta Katayama, Chang Ki Min, Ho-Jin Shin, Jin Seok Kim, Jung Yong Hong, Ki Hyun Kim, Sung-Soo Yoon, Aline Ramirez, Alvaro Cabrera, Christian Ramos, David Gomez Almaguer, Deborah Martinez, Guillermo Ruiz, Helen Dayani Caballero, Juan Antonio Flores Jimenez, Annemiek Broijl, Laurens Nieuwenhuizen, Monique Minnema, Paula Ypma, Wilfried Roeloffzen, Dominik Dytfeld, Grzegorz Charlinski, Grzegorz Helbig, Krzysztof Jamroziak, Sebastian Grosicki, Wieslaw Jedrzejczak, Albert Oriol Rocafiguera, Elham Askari, Fernando Escalante Barrigon, Isabel Krsnik Castello, Javier De la Rubia Comos, Jesus Martin Sanchez, Joaquin Martinez Lopez, Jose Angel Hernandez Rivas, Luis Felipe Casado Montero, Maria Jesus Blanchard Rodriguez, Maria Teresa Cibeira Lopez, Maria Victoria Mateos Manteca, Marta Sonia Gonzalez Perez, Mercedes Gironella Mesa, Rafael Rios Tamayo, Ramon Lecumberri Villamediana, Ricarda Garcia Sanchez, Sunil Lakhwani, Yolanda Gonzalez, Hareth Nahi, Kristina Carlsson, Markus Hansson, Ulf-Henrik Mellqvist, Ali Unal, Burhan Ferhanoglu, Hayri Ozsan, Levent Undar, Mehmet Turgut, Mehmet Yilmaz, Meral Beksac, Muhlis Cem Ar, Muzaffer Demir, Sevgi Besisik, Ashutosh Wechalekar, Jamie Cavenagh, Jim Cavet, Mark Cook, Rachel Hall, Adam Waxman, Anuj Mahindra, Cesar Rodriguez Valdes, Christine Ye, Craig Reeder, Daphne Friedman, David Siegel, Divaya Bhutani, Edward Libby, Eva Medvedova, Frank Passero, Giada Bianchi, Giampaolo Talamo, Guido Tricot, Hans Lee, Heather Landau, Jan Moreb, Jason Valent, Jeffrey Matous, Jeffrey A Zonder, Jesus Berdeja, Jonathan Kaufman, Keith Stockerl-Goldstein, Keren Osman, Ketan Doshi, Kevin Barton, Larry Anderson, Manisha Bhutani, Mehmet Kocoglu, Michael Rosenzweig, Michael Schuster, Michaela Liedtke, Morie Gertz, Naresh Bumma, Natalie Callander, Raymond Comenzo, Robert Vescio, Roger Pearse, Sandy W Wong, Stacey A Goodman, Stefano Tarantolo, Taimur Sher, Tibor Kovacsovics, Tomer Mark, Vaishali Sanchorawala, William Bensinger, Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne (UCA), Kastritis E., Palladini G., Minnema M.C., Wechalekar A.D., Jaccard A., Lee H.C., Sanchorawala V., Gibbs S., Mollee P., Venner C.P., Lu J., Schonland S., Gatt M.E., Suzuki K., Kim K., Cibeira M.T., Beksac M., Libby E., Valent J., Hungria V., Wong S.W., Rosenzweig M., Bumma N., Huart A., Dimopoulos M.A., Bhutani D., Waxman A.J., Goodman S.A., Zonder J.A., Lam S., Song K., Hansen T., Manier S., Roeloffzen W., Jamroziak K., Kwok F., Shimazaki C., Kim J.-S., Crusoe E., Ahmadi T., Tran N., Qin X., Vasey S.Y., Tromp B., Schecter J.M., Weiss B.M., Zhuang S.H., Vermeulen J., Merlini G., and Comenzo R.L., Bradley Augustson, Fiona Kwok, Peter Mollee, Simon Gibbs, Chantal Doyen, Greet Bries, Isabelle Vande Broek, Ka Lung Wu, Koen Theunissen, Koen Van Eygen, Michel Delforge, Nathalie Meuleman, Philip Vlummens, Angelo Maiolino, Breno Moreno de Gusmão, Carlos Eduardo Miguel, Edvan Crusoe, Fernanda Moura, Fernanda Seguro, Jandey Bigonha, Juliane Musacchio, Karla Zanella, Laura Garcia, Marcelo Eduardo Zanella Capra, Reijane Alves de Assis, Rosane Bittencourt, Vania Hungria, Walter Braga, Wolney Barreto, Christopher Venner, Donna Reece, Emilie Lemieux-Blanchard, Kevin Song, Michael Sebag, Selay Lam, Victor Zepeda, Haitao Zhang, Jianda Hu, Jin Lu, Juan Li, Songfu Jiang, Ting Niu, Wenming Chen, Xiaonong Chen, Zhen Cai, Zhou Fude, Maja Oelholm Vase, Morten Salomo, Niels Abildgaard, Alain Fuzibet, Anne-Marie Stoppa, Arnaud Jaccard, Bertrand Arnulf, Bruno Moulin, Bruno Royer, David Ghez, Denis Caillot, Dominique Chauveau, Franck Bridoux, Lauriane Clement-Filliatre, Lionel Karlin, Lotfi Benboubker, Mamoun Dib, Margaret Macro, Mohamad Mohty, Olivier Decaux, Olivier Hermine, Olivier Tournilhac, Philippe Moreau, Salomon Manier, Sylvain Choquet, Véronique Dorvaux, Alexander Carpinteiro, Axel Nogai, Britta Besemer, Christoph Roellig, Roland Fenk, Stefan Knop, Stefan Schönland, Timon Hansen, Argiris Symeonidis, Efstathios Kastritis, Gabor Mikala, Tamás Masszi, Zsolt Nagy, Celia Suriu, Hila Magen, Iuliana Vaxman, Lev Shvidel, Meir Preis, Moshe Gatt, Noa Lavi, Osnat Jarchowsky, Tamar Tadmor, Yael Cohen, Angelo Vacca, Giovanni Palladini, Mario Boccadoro, Maurizio Martelli, Maurizio Musso, Michele Cavo, Chihiro Shimazaki, Hiroyuki Takamatsu, Kazutaka Sunami, Kenshi Suzuki, Nagaaki Katoh, Shinsuke Iida, Takayuki Ikezoe, Tomoaki Fujisaki, Yuta Katayama, Chang Ki Min, Ho-Jin Shin, Jin Seok Kim, Jung Yong Hong, Ki Hyun Kim, Sung-Soo Yoon, Aline Ramirez, Alvaro Cabrera, Christian Ramos, David Gomez Almaguer, Deborah Martinez, Guillermo Ruiz, Helen Dayani Caballero, Juan Antonio Flores Jimenez, Annemiek Broijl, Laurens Nieuwenhuizen, Monique Minnema, Paula Ypma, Wilfried Roeloffzen, Dominik Dytfeld, Grzegorz Charlinski, Grzegorz Helbig, Krzysztof Jamroziak, Sebastian Grosicki, Wieslaw Jedrzejczak, Albert Oriol Rocafiguera, Elham Askari, Fernando Escalante Barrigon, Isabel Krsnik Castello, Javier De la Rubia Comos, Jesus Martin Sanchez, Joaquin Martinez Lopez, Jose Angel Hernandez Rivas, Luis Felipe Casado Montero, Maria Jesus Blanchard Rodriguez, Maria Teresa Cibeira Lopez, Maria Victoria Mateos Manteca, Marta Sonia Gonzalez Perez, Mercedes Gironella Mesa, Rafael Rios Tamayo, Ramon Lecumberri Villamediana, Ricarda Garcia Sanchez, Sunil Lakhwani, Yolanda Gonzalez, Hareth Nahi, Kristina Carlsson, Markus Hansson, Ulf-Henrik Mellqvist, Ali Unal, Burhan Ferhanoglu, Hayri Ozsan, Levent Undar, Mehmet Turgut, Mehmet Yilmaz, Meral Beksac, Muhlis Cem Ar, Muzaffer Demir, Sevgi Besisik, Ashutosh Wechalekar, Jamie Cavenagh, Jim Cavet, Mark Cook, Rachel Hall, Adam Waxman, Anuj Mahindra, Cesar Rodriguez Valdes, Christine Ye, Craig Reeder, Daphne Friedman, David Siegel, Divaya Bhutani, Edward Libby, Eva Medvedova, Frank Passero, Giada Bianchi, Giampaolo Talamo, Guido Tricot, Hans Lee, Heather Landau, Jan Moreb, Jason Valent, Jeffrey Matous, Jeffrey A Zonder, Jesus Berdeja, Jonathan Kaufman, Keith Stockerl-Goldstein, Keren Osman, Ketan Doshi, Kevin Barton, Larry Anderson, Manisha Bhutani, Mehmet Kocoglu, Michael Rosenzweig, Michael Schuster, Michaela Liedtke, Morie Gertz, Naresh Bumma, Natalie Callander, Raymond Comenzo, Robert Vescio, Roger Pearse, Sandy W Wong, Stacey A Goodman, Stefano Tarantolo, Taimur Sher, Tibor Kovacsovics, Tomer Mark, Vaishali Sanchorawala, William Bensinger
- Subjects
Male ,Treatment outcome ,Immunoglobulin Light-chain Amyloidosis/drug therapy ,CD38 ,Dexamethasone ,Cyclophosphamide/administration & dosage ,Bortezomib ,0302 clinical medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,CRITERIA ,Immunoglobulin Light-chain Amyloidosis ,ComputingMilieux_MISCELLANEOUS ,Aged, 80 and over ,biology ,Amyloidosis ,Antibodies, Monoclonal ,[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology ,General Medicine ,Middle Aged ,3. Good health ,Treatment Outcome ,030220 oncology & carcinogenesis ,Female ,Antibody ,Human ,Adult ,Dexamethasone/administration & dosage ,ANTIBODY DARATUMUMAB ,Immunoglobulin light chain ,DIAGNOSIS ,Antibodies, Monoclonal/administration & dosage ,Disease-Free Survival ,03 medical and health sciences ,Humans ,Cyclophosphamide ,Aged ,Antineoplastic Combined Chemotherapy Protocol ,business.industry ,Antineoplastic Combined Chemotherapy Protocols/adverse effects ,AL AMYLOIDOSIS ,Daratumumab ,Amyloid fibril ,medicine.disease ,Molecular biology ,Immunoglobulin Light-chain Amyloidosi ,biology.protein ,Bortezomib/administration & dosage ,business ,030215 immunology - Abstract
Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by deposition of amyloid fibrils of light chains produced by clonal CD38+ plasma cells. Daratumumab, a human CD38-targeting antibody, may improve outcomes for this disease.We randomly assigned patients with newly diagnosed AL amyloidosis to receive six cycles of bortezomib, cyclophosphamide, and dexamethasone either alone (control group) or with subcutaneous daratumumab followed by single-agent daratumumab every 4 weeks for up to 24 cycles (daratumumab group). The primary end point was a hematologic complete response.A total of 388 patients underwent randomization. The median follow-up was 11.4 months. The percentage of patients who had a hematologic complete response was significantly higher in the daratumumab group than in the control group (53.3% vs. 18.1%) (relative risk ratio, 2.9; 95% confidence interval [CI], 2.1 to 4.1; P0.001). Survival free from major organ deterioration or hematologic progression favored the daratumumab group (hazard ratio for major organ deterioration, hematologic progression, or death, 0.58; 95% CI, 0.36 to 0.93; P = 0.02). At 6 months, more cardiac and renal responses occurred in the daratumumab group than in the control group (41.5% vs. 22.2% and 53.0% vs. 23.9%, respectively). The four most common grade 3 or 4 adverse events were lymphopenia (13.0% in the daratumumab group and 10.1% in the control group), pneumonia (7.8% and 4.3%, respectively), cardiac failure (6.2% and 4.8%), and diarrhea (5.7% and 3.7%). Systemic administration-related reactions to daratumumab occurred in 7.3% of the patients. A total of 56 patients died (27 in the daratumumab group and 29 in the control group), most due to amyloidosis-related cardiomyopathy.Among patients with newly diagnosed AL amyloidosis, the addition of daratumumab to bortezomib, cyclophosphamide, and dexamethasone was associated with higher frequencies of hematologic complete response and survival free from major organ deterioration or hematologic progression. (Funded by Janssen Research and Development; ANDROMEDA ClinicalTrials.gov number, NCT03201965.).
- Published
- 2021
- Full Text
- View/download PDF
7. Do you have COVID-19? How to increase the use of diagnostic and contact tracing apps
- Author
-
Ana María Rojas, Deborah Martinez, Cristina Parilli, Alberto Simpser, and Carlos Scartascini
- Subjects
Male ,Mexican People ,Viral Diseases ,Information privacy ,Facebook ,020205 medical informatics ,Epidemiology ,Social Sciences ,02 engineering and technology ,Surveys ,Geographical locations ,Medical Conditions ,Promotion (rank) ,Sociology ,Surveys and Questionnaires ,Medicine and Health Sciences ,0202 electrical engineering, electronic engineering, information engineering ,Ethnicities ,Virus Testing ,media_common ,Multidisciplinary ,05 social sciences ,Social Communication ,Software Engineering ,Middle Aged ,Population groupings ,Survey experiment ,Mobile Applications ,Infectious Diseases ,Social Networks ,Privacy ,Research Design ,Engineering and Technology ,Medicine ,Female ,Psychology ,Network Analysis ,Research Article ,Adult ,Computer and Information Sciences ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,media_common.quotation_subject ,Science ,Control (management) ,Internet privacy ,Research and Analysis Methods ,050105 experimental psychology ,Computer Software ,Diagnostic Medicine ,mental disorders ,Humans ,0501 psychology and cognitive sciences ,Pandemics ,Mexico ,Government ,Survey Research ,business.industry ,COVID-19 ,Latin American people ,Covid 19 ,Apps ,Communications ,Medical Risk Factors ,North America ,Contact Tracing ,People and places ,business ,Social Media ,Contact tracing - Abstract
Diagnostic and contact tracing apps are a needed weapon to contain contagion during a pandemic. We study how the content of the messages used to promote the apps influence adoption by running a survey experiment on approximately 23,000 Mexican adults. Respondents were randomly assigned to one of three different prompts, or a control condition, before stating their willingness to adopt a diagnostic app and contact tracing app. The prompt emphasizing government efforts to ensure data privacy, which has been one of the most common strategies, reduced willingness to adopt the apps by about 4 pp and 3 pp, respectively. An effective app promotion policy must understand individuals’ reservations and be wary of unintended reactions to naïve reassurances.
- Published
- 2021
8. Let’s (not) get together! The role of social norms on social distancing during COVID-19
- Author
-
Cristina Parilli, Carlos Scartascini, Alberto Simpser, and Deborah Martinez
- Subjects
Male ,Viral Diseases ,Mexican People ,Facebook ,Epidemiology ,Social Sciences ,Surveys ,Social Distancing ,Geographical locations ,Medical Conditions ,Sociology ,Surveys and Questionnaires ,Medicine and Health Sciences ,Social Norms ,Ethnicities ,Public and Occupational Health ,COVID-19 ,Public and occupational health ,Mexico ,Social distancing ,Mexican people ,Pandemics ,Multidisciplinary ,Social distance ,Social Communication ,Population groupings ,Middle Aged ,Infectious Diseases ,Social Networks ,Research Design ,Respondent ,Quarantine ,Medicine ,Female ,Psychology ,Social psychology ,Network Analysis ,Research Article ,Adult ,2019-20 coronavirus outbreak ,Computer and Information Sciences ,Coronavirus disease 2019 (COVID-19) ,Infectious Disease Control ,Science ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Physical Distancing ,Media coverage ,Research and Analysis Methods ,Compliance (psychology) ,Humans ,Aged ,Survey Research ,Covid 19 ,Latin American people ,Communications ,North America ,Normative ,People and places ,Social Media - Abstract
While effective preventive measures against COVID-19 are now widely known, many individuals fail to adopt them. This article provides experimental evidence about one potentially important driver of compliance with social distancing: social norms. We asked each of 23,000 survey respondents in Mexico to predict how a fictional person would behave when faced with the choice about whether or not to attend a friend’s birthday gathering. Every respondent was randomly assigned to one of four social norms conditions. Expecting that other people would attend the gathering and/or believing that other people approved of attending the gathering both increased the predicted probability that the fictional character would attend the gathering by 25%, in comparison with a scenario where other people were not expected to attend nor to approve of attending. Our results speak to the potential effects of communication campaigns and media coverage of compliance with, and normative views about, COVID-19 preventive measures. They also suggest that policies aimed at modifying social norms or making existing ones salient could impact compliance.
- Published
- 2021
- Full Text
- View/download PDF
9. The history of dyes: Deborah Martinez Martinez looks at the colorful history of dyes
- Author
-
Martinez, Deborah Martinez
- Subjects
Dyes and dyeing -- History ,Dyes and dyeing -- Production processes ,History - Published
- 2006
10. P963: EXTRAMEDULLARY MULTIPLE MYELOMA: CLINICAL CHARACTERISTICS, IMPACT, AND OUTCOMES IN A COHORT OF PATIENTS IN MEXICO
- Author
-
Amaya Llorente Chávez, Sergio Rodriguez-Rodriguez, Antonio Olivas Martínez, Cesar Omar Vargas-Serafin, Christianne Bourlon De Los Rios, and Deborah Martínez Baños
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
11. PB2116: CASTLEMAN’S DISEASE: DIFFERENT CLINICAL BEHAVIOR AND PATHOLOGIC RECLASSIFICATION OF A COHORT OF MEXICAN PATIENTS
- Author
-
Alfonso Orozco Collazo, Daniel Montante Montes de Oca, María José Lizardo Thiebaud, Beatriz Eugenia Sánchez Hernández, Sergio Rodriguez-Rodriguez, Cinthya Monroy Ramos, Berta Riveros Gilardi, Alec Seidman Sorsby, José de Jesús Sandoval López, Isabel García Carrera, and Deborah Martínez Baños
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
12. PB2577: INFECTIONS AND THEIR RELATIONSHIP WITH EARLY MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA
- Author
-
Juan Luis Ontiveros-Austria, Sergio Rodriguez-Rodriguez, Sandra Rajme López, Alfonso Orozco Collazo, Santiago Riviello Goya, Aldo Alejandro Silva Esparza, Sofía Ávila Luna, Alec Seidman Sorsby, and Deborah Martínez Baños
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
13. Behavior Breakthroughs™: Future Teachers Reflect on a Focused Game Designed to Teach ABA Techniques
- Author
-
Deborah Martinez, John Lowdermilk, Carey Lowdermilk, Julie Pecina, and Lisa Beccera
- Subjects
ComputingMilieux_PERSONALCOMPUTING ,Educational technology ,medicine.disease ,Special education ,Electronic learning ,Teacher education ,Computer Science Applications ,Education ,Pedagogy ,ComputingMilieux_COMPUTERSANDEDUCATION ,medicine ,Autism ,College instruction ,Behavior management ,Psychology ,Educational game - Abstract
This article examines the use of a focused educational game. The game, Behavior Breakthroughs™, was created to teach people that work with children with autism, appropriate behavior management techniques. A group of undergraduate, teacher education students played the game and provided feedback on their experiences.
- Published
- 2012
- Full Text
- View/download PDF
14. Chronic Myeloid Leukemia: A Clinicoepidemiologic and Therapeutic Description of a Single Institution in Mexico City
- Author
-
Yael Cazares-Ordonez, Elizabeth Guadarrama-Beltran, Erick Crespo-Solís, Alvaro Aguayo, Xavier López-Karpovitch, Eduardo E. Cervera-Ceballos, Eunice Garcia-Alvarez, and Deborah Martinez-Baños
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Cytogenetics ,Myeloid leukemia ,Imatinib ,General Medicine ,Philadelphia chromosome ,medicine.disease ,Imatinib mesylate ,hemic and lymphatic diseases ,Mexico city ,Internal medicine ,Immunology ,Cohort ,Medicine ,business ,medicine.drug ,Fluorescence in situ hybridization - Abstract
Background: Chronic myeloid leukemia (CML) is a malignant disease caused by the protein coded by the Philadelphia chromosome. Imatinib mesylate (IM) is now the treatment of choice for all stages of CML. Clinicoepidemiologic information on CML from developing countries is scattered in the current literature. Patients and Methods: We report on the clincoepidemiologic features and response to therapy with IM in a cohort of patients with all stages of CML at a Mexican institution. Additionally, we describe the failure rate of standard G-banding cytogenetics, and correlate the association of successful standard cytogenetics with fluorescence in situ hybridization (FISH) to validate the results of responses in our patient population. Ninety-nine medical charts were evaluated. Fifty-seven patients were treated with IM, and a historical group consisted of 42 patients. Results: The median age was 37 years, and the median follow-up of the IM-treated cohort was 26.4 months. The correlation between cytogenetics and FISH was 0.719 (P = .01). The complete cytogenetic response was 88.1% in the IM-treated group, versus 4.8% in the historical group. Patients previously treated with interferon-α (INF-α) had a complete cytogenetic response of 58.8%, versus 77.8% of patients previously treated who were naive to INF-α. Conclusion: Our report describes a comprehensive picture of a group of patients with CML representative of the Mexican population with socioeconomic and cultural constraints. Except for median age at diagnosis, clinicoepidemiologic features and response rates are in accordance with other series. Fluorescence in situ hybridization was a reliable method for monitoring CML at our institution. However, the role of FISH in monitoring CML, where standard cytogenetic testing and the polymerase chain reaction are less reliable, needs to be clarified more thoroughly.
- Published
- 2008
- Full Text
- View/download PDF
15. Refractive index sensing in high-refractive-index liquids based on tapered fiber optic coated with silicon nitride thin film
- Author
-
R. Domínguez-Cruz, Daniel A. May-Arrioja, Deborah Martinez-Camacho, and Oscar Baldovino-Pantaleón
- Subjects
Reproducibility ,Materials science ,Optical fiber ,genetic structures ,business.industry ,High-refractive-index polymer ,eye diseases ,law.invention ,chemistry.chemical_compound ,Optics ,Silicon nitride ,chemistry ,law ,Optical materials ,Optoelectronics ,sense organs ,Thin film ,business ,Sensitivity (electronics) ,Refractive index - Abstract
Sensor based on tapered optical fiber with silicon nitride thin film to increase its sensitivity. Sensing experiments on several concentrations of glycerol in deionized water reaches sensitivity of 291 nm/RIU, with high reproducibility and reversible.
- Published
- 2016
- Full Text
- View/download PDF
16. Development and Production of Cascade and Chinook Fields in the Gulf of Mexico: An Overview
- Author
-
Ribeiro Orlando Jose Soares, Salvador da Matta Jr., Cesar L. Palagi, and Deborah Martinez de Mattos
- Subjects
Chinook wind ,Oceanography ,Cascade ,Environmental science - Abstract
Abstract This paper is based on the work performed during the design, implementation and operation of the Cascade and Chinook fields, located offshore the United States Gulf of Mexico (USGoM) - the first deployment of an FPSO in the region. It presents an overview of the reservoir rock and fluid properties, the design and construction of wells, the design and installation of the subsea system and FPSO BW Pioneer, the oil export system through shuttle tankers, the gas export through pipelines and the regulatory framework of the project. It also presents operational information about the first wells on stream in each field. The information provided in this paper is a useful reference for petroleum field operators when designing development concepts for ultra-deep water discoveries, not only in the USGoM but also worldwide. It is especially useful for the design of field development and early production systems located far from pipeline infrastructure. It is useful for contractors to identify the technologies which are most suited for application on deep wells and ultra-deep water subsea systems and production platforms. The initial phase of development, already implemented, consists of two subsea wells in Cascade and one in Chinook tied back, through a field-specific subsea system, to a Floating, Production, Storage and Offloading (FPSO) platform. Oil is transported from the FPSO in shuttle vessels to terminals of opportunity along the USGoM and gas is exported through pipeline. Wells started-up production in 2012. Future phases of development will depend on the performance of the wells.
- Published
- 2013
- Full Text
- View/download PDF
17. Interpreting the past
- Author
-
Martinez, Deborah Martinez
- Subjects
Historic sites ,Historical museums ,General interest - Abstract
Do you like to READ about the past? These children 'LIVE IT' to help us understand it. Nearly 100 years after the Ranch of the Swallows (pages 6-8) was settled, [...]
- Published
- 2014
18. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation
- Author
-
Alejandra González-Duarte, Mauricio Berenguer-Sanchez, Guillermo García-Ramos, Deborah Martinez-Baños, Bruno Estañol Vidal, Carlos Cantú-Brito, Karla Cárdenas Soto, Jazmin Arteaga-Vazquez, and Fausto Barrera
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Amyloid ,Adolescent ,Biopsy ,DNA Mutational Analysis ,Polyneuropathies ,Sex Factors ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Prealbumin ,Age of Onset ,Mexico ,Genetic testing ,medicine.diagnostic_test ,biology ,business.industry ,Genetic heterogeneity ,Amyloidosis ,Middle Aged ,medicine.disease ,Pedigree ,Transthyretin ,Anticipation (genetics) ,Mutation ,biology.protein ,Female ,Age of onset ,business ,Polyneuropathy ,Amyloidosis, Familial - Abstract
Background: The phenotypic heterogeneity of transthyretin amyloidosis (ATTR) familial polyneuropathy may be linked to the type of mutation and to the environmental factors. A gender difference in relation to the severity of the disease has been suspected. More than 100 different pathogenic variants of hereditary transthyretin (TTR) mutations have been reported. Objective: To describe 32 patients with confirmed TTR Ser50Arg mutation from the same geographical origin. Methods: Seven families with up to four affected generations underwent genetic testing and prospective clinical and laboratory evaluations. Results: The mutation was confirmed in seven patients from different families with clinical symptoms compatible with ATTR amyloidosis, and in 25 (62%) of the 40 direct relatives tested. Of the 32 patients with positive test results, 18 (56%) were men. Only 5 (16%) subjects were disease-free at the time of the genetic test (mean age: 20, range: 18–30-year-old). The rest developed symptoms at a young age, between ages 36 and 41. Symptomatic, histologically positive patients were older than carriers and symptomatic patients without a confirmatory biopsy. The later generation displayed symptoms at a younger age. Initial manifestations in the 27 symptomatic patients were neuropathic in 19 (70%), gastrointestinal in 6 (22%) and autonomic in 1 (4%). Significant differences were demonstrated among genders, where men had a considerably worse outcome. Conclusion: ATTR Ser50Arg mutation was associated with an early onset, an unbalanced male to female ratio, a more aggressive course in males and possibly displayed anticipation.
- Published
- 2012
19. Familial Amyloid Polyneuropathy Associated with S50A, S52P and G47A Mutations (P03.185)
- Author
-
Carlos Cantú-Brito, Deborah Martinez-Baños, Mauricio Berenguer-Sanchez, Bruno Estañol, Karla Cardenas-Soto, Maria Alejandra Gonzalez Duarte, and Guillermo García-Ramos
- Subjects
medicine.medical_specialty ,biology ,medicine.drug_class ,business.industry ,Amyloidosis ,Disease ,medicine.disease ,Gastroenterology ,Natural history ,Transthyretin ,Orthostatic vital signs ,Estrogen ,Weight loss ,Internal medicine ,biology.protein ,medicine ,Neurology (clinical) ,medicine.symptom ,business ,Lipoprotein - Abstract
Objective: We aim to describe the main characteristics of patients with 3 different TTR mutations. Background Familial amyloid polyneuropathy is a late-onset inherited amyloidosis associated with a mutation on the transthyretin (TTR) gene. Marked diversity exists in clinical characteristics. Design/Methods: 33 patients from 10 different families with proven TTR mutation (27 S50A, 4 S52P, and 2 G47A) underwent prospective neurologic and autonomic examination. All evaluations were performed in a period of 12 months. Results: 19 male and 14 women were included. Age at onset was later in the patients with G47A mutation (33 vs 38 vs 42 yo). S52P had more weight loss (mean of 26kg vs 12-13kg) Initial symptoms were neuropathic in 66%, gastrointestinal in 18% and autonomic in 3%. Overall, men had a more severe form of the disease and worse prognosis. Specifically, men showed more GI (15 vs 11, p:0.001), GU (4 vs 13, p:0.17), and autonomic (13 vs 5, p:0.039) symptoms, had further weight loss (13±17 vs 8±4 kg, p:0.005), orthostatic SBP fall (26±15 vs 4.5±10 mmHg, p:0.01), and decreased NCV amplitudes (sensitive median 4.40 vs 7.20mV p:0.040, sural 2.5 vs 10.4mV p:0.000, motor median 2.4 vs 4.4mV p:0.014, and tibial 2.7 vs 5.8mV p:0.000 nerves). Three men (15.7%) and one woman (7.2%) died during the study period. The men died at a younger age (44±3.5 vs 62, p:0.049). Conclusions: S52P mutation showed a more aggressive course. Because the hereditary mode is autosomal dominant, no gender differences should be expected. However, 1-2% of plasma TTR circulates bound to high-density lipoprotein (HDL). The higher HDL levels associated with estrogen could explain these differences. Men should be considered for earlier liver transplant or pharmacologic treatment when available. It is possible that measures aimed to increase HDL may have some impact in the natural history of the disease. Disclosure: Dr. Gonzalez Duarte has nothing to disclose. Dr. Cardenas-Soto has nothing to disclose. Dr. Berenguer-Sanchez has nothing to disclose. Dr. Martinez-Banos has nothing to disclose. Dr. Estanol has nothing to disclose. Dr. Garcia-Ramos has nothing to disclose. Dr. Cantu-Brito has nothing to disclose.
- Published
- 2012
- Full Text
- View/download PDF
20. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
- Author
-
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, Lina M. Abenoza, Gladys P. Agreda, Jorge Armenta, Celso Arrais, Oscar Avendaño Flores, Fernando Barroso, Ana L. Basquiera, Carmen Cao, Maria S. Cugliari, Alicia Enrico, Laura M. Foggliatto, Kenny M. Galvez, David Gomez, Alvaro Gomez, Daniel de Iracema, Danielle Farias, Lineth Lopez, William Armando Mantilla, Deborah Martínez, Maria Jose Mela, Carlos E. Miguel, Roberto Ovilla, Luis Palmer, Carolina Pavlovsky, Christian Ramos, Guillermina Remaggi, Rodrigo Santucci, Sergio Schusterschitz, Claudia Lucia Sossa, Elena Tuna-Aguilar, Jorge Vela, Telma Santos, Odin de la Mora, Gerardo Machnicki, Mariana Fernandez, and Paula Barreyro
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PURPOSE: Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describe patient characteristics and treatment patterns of Latin American patients with MM, CLL, and NHL. METHODS: This study was a multicenter, retrospective, medical chart review of patients with MM, CLL, and NHL in Latin America identified between January 1, 2006, and December 31, 2015. Included were adults with at least 1 year of follow-up (except in cases of death within 1 year of diagnosis) treated at 30 oncology hospitals (Argentina, 5; Brazil, 9; Chile, 1; Colombia, 5; Mexico, 6; Panama/Guatemala, 4). RESULTS: Of 5,140 patients, 2,967 (57.7%) had NHL, 1,518 (29.5%) MM, and 655 (12.7%) CLL. Median follow-up was 2.2 years for MM, 3.0 years for CLL, and 2.2 years for NHL, and approximately 26% died during the study observation period. Most patients had at least one comorbidity at diagnosis. The most frequent induction regimen was thalidomide-based chemotherapy for MM and chlorambucil with or without prednisone for CLL. Most patients with NHL had diffuse large B-cell lymphoma (DLBCL; 49.1%) or follicular lymphoma (FL; 19.5%). The majority of patients with DLBCL or FL received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. CONCLUSION: The HOLA study generated an unprecedented level of high-quality, real-world evidence on characteristics and treatment patterns of patients with hematologic malignancies. Regional disparities in patient characteristics may reflect differences in ethnoracial identity and level of access to care. These data provide needed real-world evidence to understand the disease landscape in Latin America and may be used to inform clinical and health policy decision making.
- Published
- 2019
- Full Text
- View/download PDF
21. Let's (not) get together! The role of social norms on social distancing during COVID-19.
- Author
-
Déborah Martínez, Cristina Parilli, Carlos Scartascini, and Alberto Simpser
- Subjects
Medicine ,Science - Abstract
While effective preventive measures against COVID-19 are now widely known, many individuals fail to adopt them. This article provides experimental evidence about one potentially important driver of compliance with social distancing: social norms. We asked each of 23,000 survey respondents in Mexico to predict how a fictional person would behave when faced with the choice about whether or not to attend a friend's birthday gathering. Every respondent was randomly assigned to one of four social norms conditions. Expecting that other people would attend the gathering and/or believing that other people approved of attending the gathering both increased the predicted probability that the fictional character would attend the gathering by 25%, in comparison with a scenario where other people were not expected to attend nor to approve of attending. Our results speak to the potential effects of communication campaigns and media coverage of compliance with, and normative views about, COVID-19 preventive measures. They also suggest that policies aimed at modifying social norms or making existing ones salient could impact compliance.
- Published
- 2021
- Full Text
- View/download PDF
22. Do you have COVID-19? How to increase the use of diagnostic and contact tracing apps.
- Author
-
Deborah Martínez, Cristina Parilli, Ana María Rojas, Carlos Scartascini, and Alberto Simpser
- Subjects
Medicine ,Science - Abstract
Diagnostic and contact tracing apps are a needed weapon to contain contagion during a pandemic. We study how the content of the messages used to promote the apps influence adoption by running a survey experiment on approximately 23,000 Mexican adults. Respondents were randomly assigned to one of three different prompts, or a control condition, before stating their willingness to adopt a diagnostic app and contact tracing app. The prompt emphasizing government efforts to ensure data privacy, which has been one of the most common strategies, reduced willingness to adopt the apps by about 4 pp and 3 pp, respectively. An effective app promotion policy must understand individuals' reservations and be wary of unintended reactions to naïve reassurances.
- Published
- 2021
- Full Text
- View/download PDF
23. Language as a Barrier to Health Care
- Author
-
Jennifer Sternbach de Medina, Elizabeth A. Leone, and Deborah Martinez
- Subjects
Nursing ,business.industry ,Health care ,business ,Psychology - Published
- 1985
- Full Text
- View/download PDF
24. General recital hour
- Author
-
Phillips, Cheryl; Spacke, Deborah; Martinez, Miguel; Burke, Denis M.; Rivar, Jane; Braun, Linsey, Ball State University. School of Music, Phillips, Cheryl; Spacke, Deborah; Martinez, Miguel; Burke, Denis M.; Rivar, Jane; Braun, Linsey, and Ball State University. School of Music
- Abstract
With Cheryl Phillips, flute, Deborah Spacke, piano, Michael Martinez, violoncello, Denis M. Burke, guitar, Jane Rivar, flute, and Linsey Braun, piano., Series XXVII, Number 127., This archival material has been provided for educational purposes. Ball State University Libraries recognizes that some historic items may include offensive content. Our statement regarding objectionable content is available at: https://dmr.bsu.edu/digital/about
- Published
- 1973
25. Extramedullary Plasmacytoma of the Larynx: A Case Report of Subglottic Localization
- Author
-
Jaqueline Ramírez-Anguiano, Hugo Lara-Sánchez, Deborah Martínez-Baños, and Braulio Martínez-Benítez
- Subjects
Otorhinolaryngology ,RF1-547 - Abstract
Extramedullary plasmacytoma (EMP) is a rare neoplasm of plasma cells, described in soft tissue outside the bone marrow. EMP of the larynx represents 0.04 to 0.45% of malignant tumors of the larynx. A male of 57 years old presented with hoarseness, dyspnea, and biphasic stridor of 2 months. The indirect laryngoscopy (IL) revealed severe edema of the posterior commissure and a polypoid mass in the right posterior lateral subglottic wall. A biopsy of the subglottic mass was performed by a direct laryngoscopy (DL). The histopathologic diagnosis was EMP CD138+, therefore radiotherapy was given at 54 Gy in 30 sessions. The patient had an adequate postoperative clinical course and a new biopsy was performed having tumor-free margins. All laryngeal lesions should be biopsied prior to treatment to determine an accurate diagnosis to guide a proper management of the condition. Radiation therapy to the EMP is considered the treatment of choice, having local control rates of 80% to 100%. The subglottis is the least accessible area of view and the least frequent location of a laryngeal mass, nevertheless the otolaryngologist should always do a complete and systematic exam of the larynx when a tumor is suspected, to detect diagnoses such as a subglottic plasmacytoma.
- Published
- 2012
- Full Text
- View/download PDF
26. Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides
- Author
-
Alfonso Dueñas-Gonzalez, Maria Teresa Vega, Déborah Martinez-Baños, Linda García-Hidalgo, and Pedro Sobrevilla
- Subjects
Medicine - Abstract
Histone deacetylase (HDAC) inhibitors have shown significant activity in the treatment of cutaneous T-cell lymphomas (CTCL). The epigenetic alterations of CTCL not only are limited to altered histone acetylation but also include aberrant DNA gene methylation hence, the combination of an HDAC inhibitor with a DNA demethylating agent is a promising therapy to be tested. Here we report a mycosis fungoides patient having a dramatic response to hydralazine and valproate, two repositioned drugs as HDAC and DNA methylation inhibitors, respectively.
- Published
- 2010
- Full Text
- View/download PDF
27. Regulatory Role of Retinoic Acid on Cultured Mouse Keratinocyte Inositol Phospholipid Metabolism: Dose-dependent Release of Inositol Triphosphate.
- Author
-
Wilson Tang, Vincent A. Ziboh, Rivkah Isseroff, and Deborah Martinez
- Subjects
- *
TRETINOIN , *KERATINOCYTES , *INOSITOL , *PHOSPHOLIPIDS , *HYDROLYSIS , *SOLVOLYSIS - Abstract
The incorporation of precursor 14C-myoinositol into the three cellular inositol phospholipids (PtdIns, PtdInsP, and PtdInsP2) of cultured, rapidly proliferating keratinocytes is significantly enhanced by the exogenous addition of a high concentration (1 × 10-7 M) of all-trans retinoic acid or its analog 13-Cis analog, whereas a similar incubation with a low concentration (1 × 10-10 to M) of the same retinoid resulted in an insignificant incorporation of the radio-precursor into the three inositol phospholipids. Incorporation was most marked into the more phosphorylated PtdIns4P and PtdIns4,5P2. These results indicate that retinoic acid affects the biosynthesis of the inositol phospholipids at high concentrations. In contrast, the hydrolysis of 14C-PtdIns4,5P2 and release of 14C-InsP3 from the prelabeled keratinocytes is markedly enhanced by a low physiologic concentration (1 × 10-10 M) of retinoic acid or its 13-Cis analog. The hydrolysis is rapid, with an accompanying elevated transient release of 14C-InsP3. High concentration (1 × 10-5 M), on the other hand, supresses 14C-InsP3 release. These results taken together underscore a bifunctional, dose-dependent effect of both the all-trans-RA and its 13-Cis analog on the synthesis and hydrolysis of keratinocyte PtdIns4,5P2. Furthermore, the results suggest that at low physiologic concentrations, these retinoids may function as agonists to perturb the membrane resulting in induced rapid hydrolysis of cellular PtdIns4,5P2, which is coupled to a "transient" generation of InsP3 (an intracellular second messenger). The rapid formation of this putative "second messenger" may in turn play a role in the cellular proliferative or differentiating biochemical events in the murine keratinocytes. [ABSTRACT FROM AUTHOR]
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.